Publication dates

Ovarian Cancer Industry, January 2015 Market Reports from Top Publishers

You might be interested in: cancer, medical equipment, therapeutics, breast cancer, oncology, cancer drug, drug, aids, biomarker, cancer testing, diagnostic, plc, sarcoma, stem cell.


 
1-10 of about 100 reports for Ovarian Cancer

Ovarian Cancer Drug Pathway Analyzer 2015

Ovarian Cancer Drug Pathway Analyzer 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... Seeker, a leader in pipeline analytics, has constructed this high-level drug-pathway analyzer which lets you interact with the ovarian cancer pipeline in a whole different than way than you ever done before. Its ...

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

Aposense Ltd. (Symbol:APOS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Of parkinson's disease. The company's att-11t is a therapeutic compound used in the treatment of metastatic solid tumors such as colorectal cancer, lung cancer and ovarian cancer. It markets products through ...

OXiGENE, Inc. (Symbol:OXGN) SWOT Analysis, Strategy, Revenues and Profits

OXiGENE, Inc. (Symbol:OXGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Trials for the treatment of ovarian cancer, anaplastic thyroid cancer, medullary thyroid cancer, stage iv papillary thyroid cancer, and stage iv follicular thyroid cancer. The company also offers falcon ...

Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

Viralytics Ltd. (Symbol:VLA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Also provides virotherapy technology that uses group of viruses to target cancer cells. It conducts cancer research on gastric cancer with evatak, ovarian cancer with evatak, and melanoma studies ...

Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Phase ii/b clinical trials for the treatment of pancreatic cancer and for superficial bladder carcinoma cancer, as well as a phase i/iia clinical trial for the treatment of ovarian cancer. Tikcro ...

Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis Review

Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Vax hercepti for the treatment of breast cancer and folate binding protein for the treatment of endometrial and ovarian cancer. Galena's abstral is a sublingual tablets for the management of breakthrough pain ...

Prima BioMed Ltd. (PRR) - Financial and Strategic SWOT Analysis Review

Prima BioMed Ltd. (PRR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... Immunocellular therapeutic products for cancer treatment. Its cvac therapy is an immunocellular therapeutic under investigation for the treatment of epithelial ovarian cancer. Prima biomed also provides dendritic ...

VG Life Sciences, Inc. (VGLS) - Financial and Strategic SWOT Analysis Review

VG Life Sciences, Inc. (VGLS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

... In the therapeutic areas of ovarian cancer and breast cancer, lyme disease, hiv/aids, sepsis, staph/strep infection, pandas, among others. The company conducts research and development program based on technology ...

Biological Therapies for Cancer: Technologies and Global Markets

Biological Therapies for Cancer: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

... Kidney cancerleukemialymphomaliver cancermelanomamultiple myelomabrain cancerovarian cancerpancreatic cancerprostate cancerstomach cancerhead and neck cancers ...

Ovarian Cancer Drug Pipeline Update 2015

Ovarian Cancer Drug Pipeline Update 2015

  • $ 2 249
  • Industry report
  • January 2015
  • by Bioseeker

... There are 6 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 117 drugs. ovarian cancer drug pipeline update lists all drugs and gives you a progress analysis ...

About 1 000 reports for Ovarian Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • August 2014
    25 pages
  • Cancer  

    Breast Cancer  

  • United States  

View report >

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.